Evotec SE Stock Other OTC
Stocks
EVTCY
US30050E1055
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 619M 708M 573M 526M 995M 68.27B 1.01B 6.83B 2.68B 33.34B 2.66B 2.6B 115B | P/E 2026 * |
-4.02x | P/E 2027 * | -10x |
|---|---|---|---|---|---|
| Enterprise Value | 661M 756M 611M 561M 1.06B 72.84B 1.08B 7.29B 2.86B 35.57B 2.84B 2.78B 123B | EV / Sales 2026 * |
1.1x | EV / Sales 2027 * | 0.98x |
| Free-Float |
89.91% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Evotec SE
| 1 day | +1.30% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2024-06-30 | |
| Director of Finance/CFO | - | 2026-04-30 | |
Ingrid Müller
COO | Chief Operating Officer | - | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Roland Sackers
BRD | Director/Board Member | 58 | 2019-06-18 |
| Director/Board Member | 64 | 2021-05-31 | |
| Director/Board Member | 43 | 2022-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.30% | -.--% | - | - | 713M | |
| -1.07% | +0.38% | +2.06% | +5.66% | 50.35B | |
| -2.85% | -5.58% | +373.90% | +572.09% | 39.21B | |
| +1.78% | +3.29% | +33.49% | -4.80% | 34.52B | |
| +1.98% | +5.15% | +17.69% | +61.68% | 34.6B | |
| +0.06% | -0.57% | +3.35% | +27.42% | 27.05B | |
| -3.27% | -6.27% | - | - | 16.68B | |
| +1.64% | +1.11% | +72.02% | +121.18% | 15.11B | |
| +0.29% | +3.64% | +15.30% | +17.80% | 13.85B | |
| -1.21% | +2.74% | +16.77% | -30.96% | 13.18B | |
| Average | -0.22% | +0.44% | +66.82% | +96.26% | 27.17B | |
| Weighted average by Cap. | -0.46% | +0.02% | +79.63% | +118.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 600M 686M 555M 509M 963M 66.11B 980M 6.61B 2.6B 32.28B 2.58B 2.52B 111B | 736M 842M 681M 625M 1.18B 81.15B 1.2B 8.12B 3.19B 39.63B 3.16B 3.09B 137B |
| Net income | -147M -168M -136M -125M -236M -16.22B -240M -1.62B -638M -7.92B -632M -618M -27.35B | -47.45M -54.29M -43.89M -40.27M -76.22M -5.23B -77.54M -523M -206M -2.55B -204M -199M -8.82B |
| Net Debt | 41.5M 47.48M 38.38M 35.22M 66.65M 4.57B 67.81M 458M 180M 2.23B 178M 174M 7.71B | 105M 120M 97.26M 89.25M 169M 11.59B 172M 1.16B 456M 5.66B 452M 442M 19.55B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
